Home » Authors » Holland Johnson

Articles by Holland Johnson

FDA issues rare company-wide warning letter to Boston Sci

Jan. 30, 2006

By Holland Johnson

Guidant bidding war seems at end as J&J doesn't boost offer

Jan. 26, 2006

By Holland Johnson

Deals roundup: ATS to bolster heart valve offerings with $58M 3F buy

Jan. 25, 2006

By Holland Johnson

J&J offer rumors persist as Guidant has more ICD issues

Jan. 24, 2006

By Holland Johnson

Financings roundup: CardioOptics in $26M 'B' round; InSight extends exchange date

Jan. 23, 2006

By Holland Johnson

FDA lets Cyberonics close its IDE depression studies

Jan. 20, 2006

By Holland Johnson

Boston Sci ups ante in Guidant bidding war to just over $27B

Jan. 18, 2006

By Holland Johnson

Guidant bidding war continues with $73-a-share Boston Sci bid

Jan. 17, 2006

By Holland Johnson

J&J sweetens Guidant offer to squelch Boston Sci's late bid

Jan. 13, 2006

By Holland Johnson

BD to acquire molecular test firm GeneOhm for $230 million

Jan. 12, 2006

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...